1. Home
  2. AKR vs NUVB Comparison

AKR vs NUVB Comparison

Compare AKR & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKR
  • NUVB
  • Stock Information
  • Founded
  • AKR 1993
  • NUVB 2018
  • Country
  • AKR United States
  • NUVB United States
  • Employees
  • AKR N/A
  • NUVB 291
  • Industry
  • AKR Real Estate Investment Trusts
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • AKR Real Estate
  • NUVB Health Care
  • Exchange
  • AKR Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • AKR 2.6B
  • NUVB 2.4B
  • IPO Year
  • AKR 1993
  • NUVB N/A
  • Fundamental
  • Price
  • AKR $20.11
  • NUVB $7.06
  • Analyst Decision
  • AKR Strong Buy
  • NUVB Strong Buy
  • Analyst Count
  • AKR 3
  • NUVB 8
  • Target Price
  • AKR $22.33
  • NUVB $9.50
  • AVG Volume (30 Days)
  • AKR 1.4M
  • NUVB 12.1M
  • Earning Date
  • AKR 10-28-2025
  • NUVB 11-03-2025
  • Dividend Yield
  • AKR 4.07%
  • NUVB N/A
  • EPS Growth
  • AKR 18.54
  • NUVB N/A
  • EPS
  • AKR 0.12
  • NUVB N/A
  • Revenue
  • AKR $389,489,000.00
  • NUVB $26,748,000.00
  • Revenue This Year
  • AKR N/A
  • NUVB $283.17
  • Revenue Next Year
  • AKR $10.79
  • NUVB $340.98
  • P/E Ratio
  • AKR $163.21
  • NUVB N/A
  • Revenue Growth
  • AKR 6.01
  • NUVB 1137.19
  • 52 Week Low
  • AKR $16.98
  • NUVB $1.54
  • 52 Week High
  • AKR $26.29
  • NUVB $7.50
  • Technical
  • Relative Strength Index (RSI)
  • AKR 55.64
  • NUVB 76.07
  • Support Level
  • AKR $19.57
  • NUVB $4.59
  • Resistance Level
  • AKR $20.33
  • NUVB $7.50
  • Average True Range (ATR)
  • AKR 0.40
  • NUVB 0.66
  • MACD
  • AKR 0.00
  • NUVB 0.20
  • Stochastic Oscillator
  • AKR 77.45
  • NUVB 87.57

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: